Annick Fontbonne

M.D., Ph.D.

Senior Researcher at the Inserm (French National Institute of Health and Medical Research)

Diabetes Epidemiology and Care Management

Training: Medical studies, Clermont-Ferrand University, 1974-1981 - Medical resident, Endocrinology-Diabetology, Nancy University Hospital, 1980-1983 - Researcher in training, Diabetes Epidemiology, Inserm-U21, Villejuif, 1984-1986 - Lecturer/hospital assistant, Paris 5 and 6 Universities and Broussais and Cochin hospitals, 1987-1988

Research experience

Full-time researcher, Inserm Montpellier, IRD Montpellier, Inserm Villejuif, 2004-present

Supervisor research team, with interests in 1) metabolic syndrome as a risk factor for type 2 diabetes in French overseas territories; 2) evaluation of pilot experiences for type 2 diabetes management in the Languedoc-Roussillon region; and 3) evaluation of health services for type 2 diabetes management in emerging and developing countries.

Visiting researcher, Oswaldo Cruz Foundation, Recife, Brazil, 1994-1999 and 2010-2013

Participation in the research line "Epidemiology and management of chronic diseases". Co- coordinator of three population-based studies about hypertension and diabetes management by the Brazilian Family Health Program (SERVIDIAH, INTERDIA, RedeNut, 2007-2017). Teacher and advisor to students of the public health courses offered by the research centre.

Researcher, Inserm, Villejuif, France, 1983-1993 (tenured since 1989)

Analyses of the Paris Prospective Study which contributed to support the concept of the metabolic syndrome as a risk factor for diabetes and cardiovascular disease. Design and coordination of the BIGPRO trial, first attempt to test, vs. placebo, an insulin sensitising agent, metformin, for correcting metabolic abnormalities in upper-body obese, non-diabetic subjects.